- Home
- NL vs AVTX Comparison
NL vs AVTX Comparison
Compare NL & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | AVTX |
|---|---|---|
| Founded | 1891 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.9M | 328.4M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NL | AVTX |
|---|---|---|
| Price | $5.94 | $13.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $40.57 |
| AVG Volume (30 Days) | 20.8K | ★ 779.9K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.22% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $158,285,000.00 | $27,813,137.00 |
| Revenue This Year | $9.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 8.46 | ★ 2312.27 |
| 52 Week Low | $5.04 | $3.39 |
| 52 Week High | $9.27 | $20.72 |
Technical Indicators
Market Signals| Indicator | NL | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 39.47 |
| Support Level | $5.74 | $8.87 |
| Resistance Level | $6.30 | $15.63 |
| Average True Range (ATR) | 0.14 | 1.08 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 85.94 | 9.28 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.